Bailey, Clare http://orcid.org/0000-0003-2141-4512
Cackett, Peter http://orcid.org/0000-0001-7213-2537
Kotagiri, Ajay
Mahmood, Sajjad
Minos, Evangelos
Narendran, Nirodhini
Patwardhan, Ashish
Sim, Dawn A. http://orcid.org/0000-0002-6363-7805
Morgan-Warren, Peter
O’Neil, Carolyn
Straw, Katie
Funding for this research was provided by:
Bayer plc, Reading, UK
Article History
Received: 22 April 2022
Revised: 24 August 2022
Accepted: 14 September 2022
First Online: 7 October 2022
Competing interests
: CB: Advisory board attendances for and honoraria from Bayer, Novartis, Alimera Sciences, Roche and Boehringer Ingelheim. PC: Advisory board attendances for and honoraria and travel grants from Bayer and Novartis; advisory board attendances for Roche and Allergan. AK: Advisory board attendances for Bayer, Allergan and Novartis; travel grants and speaker fees from Bayer and Novartis; research grant from Alimera Sciences. SM: Honoraria for lecturing and consulting and travel grants from Bayer and Novartis; principal investigator in multicentre research in conjunction with Bayer, Novartis and Roche. EM: Advisory committee participation for Bayer and Allergan-AbbVie; honoraria for presentations from Bayer, Allergan-AbbVie and Alimera Sciences; travel expenses from and conference attendances for Bayer, Alimera Sciences, Allergan and Novartis. NN: Advisory board attendances for and honoraria and travel grants from Bayer, Novartis and Roche. AP: Speaker honoraria and study leave grants from Bayer, Novartis, Alimera Sciences and Allergan; advisory board attendance for Bayer. DS: Speaker fees and advisory board attendances for Bayer, Novartis, Roche and Allergan; consultant for Big Picture Eye Health Ltd., Oculocare Ltd. and MTHK Ltd. PM-W: Employee of Bayer plc UK. CO: Employee of Bayer plc UK. KS: Employee of Bayer plc UK.